ATE290037T1 - Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung - Google Patents

Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung

Info

Publication number
ATE290037T1
ATE290037T1 AT98950839T AT98950839T ATE290037T1 AT E290037 T1 ATE290037 T1 AT E290037T1 AT 98950839 T AT98950839 T AT 98950839T AT 98950839 T AT98950839 T AT 98950839T AT E290037 T1 ATE290037 T1 AT E290037T1
Authority
AT
Austria
Prior art keywords
glycolide
lactide
polyethylene glycol
glycol copolymers
thermal gelation
Prior art date
Application number
AT98950839T
Other languages
English (en)
Inventor
Ramesh Rathi
Gaylen M Zentner
Byeongmoon Jeong
Original Assignee
Macromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/943,167 external-priority patent/US6004573A/en
Priority claimed from US09/164,865 external-priority patent/US6117949A/en
Application filed by Macromed Inc filed Critical Macromed Inc
Application granted granted Critical
Publication of ATE290037T1 publication Critical patent/ATE290037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/06—Biodegradable
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/14—Macromolecular compounds according to C08L59/00 - C08L87/00; Derivatives thereof
    • C08L2666/18—Polyesters or polycarbonates according to C08L67/00 - C08L69/00; Derivatives thereof
AT98950839T 1997-10-03 1998-10-02 Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung ATE290037T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/943,167 US6004573A (en) 1997-10-03 1997-10-03 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US09/164,865 US6117949A (en) 1998-10-01 1998-10-01 Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
PCT/US1998/020649 WO1999018142A1 (en) 1997-10-03 1998-10-02 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES

Publications (1)

Publication Number Publication Date
ATE290037T1 true ATE290037T1 (de) 2005-03-15

Family

ID=26860926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950839T ATE290037T1 (de) 1997-10-03 1998-10-02 Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung

Country Status (16)

Country Link
EP (1) EP1034207B1 (de)
JP (3) JP4656725B2 (de)
KR (2) KR20010030891A (de)
CN (1) CN1195788C (de)
AR (1) AR015175A1 (de)
AT (1) ATE290037T1 (de)
AU (1) AU736812B2 (de)
BR (1) BR9815239B1 (de)
CA (1) CA2305621C (de)
DE (1) DE69829204T2 (de)
ES (1) ES2239408T3 (de)
HK (1) HK1031736A1 (de)
IL (2) IL135415A0 (de)
PT (1) PT1034207E (de)
TR (1) TR200000900T2 (de)
WO (1) WO1999018142A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6841617B2 (en) * 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
US7087244B2 (en) 2000-09-28 2006-08-08 Battelle Memorial Institute Thermogelling oligopeptide polymers
CN1321092A (zh) * 1998-06-30 2001-11-07 安姆根有限公司 用于生物活性剂的延缓给药的热敏生物可降解水凝胶
WO2001041735A2 (en) * 1999-12-07 2001-06-14 Amgen Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
US7018645B1 (en) * 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
US6669959B1 (en) * 2000-07-18 2003-12-30 Aeropharm Technology Incorporated Modulated release particles for lung delivery
MXPA03004112A (es) * 2000-11-09 2003-08-19 Astrazeneca Ab Composicion farmaceutica oral que contiene un copolimero de bloque.
US20030003074A1 (en) * 2001-06-14 2003-01-02 Macromed, Inc. Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
US7226616B2 (en) 2001-07-14 2007-06-05 Samyang Corporation Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
CA2467275C (en) * 2001-11-15 2012-09-11 Biomatera Inc. Method for preparing gels
TW200307011A (en) 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
JP2006506396A (ja) 2002-10-31 2006-02-23 ファイザー・プロダクツ・インク 固体医薬の液体複合体
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
EP1642921B1 (de) 2003-07-07 2008-08-27 Nof Corporation Triblock-copolymer, herstellungsverfahren dafür und biokompatibles material
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
WO2005067890A2 (en) * 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
TW200538148A (en) * 2004-01-13 2005-12-01 Vasogenix Pharmaceuticals Inc Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
EP1555278A1 (de) * 2004-01-15 2005-07-20 Innocore Technologies B.V. Bioabbaubare Multiblock-Copolymere
AU2005299748B2 (en) * 2004-10-21 2009-04-09 Tgel Bio Co., Ltd In situ controlled release drug delivery system
WO2007067624A2 (en) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Bioabsorbable compounds and compositions containing them
DK1983990T3 (da) 2006-01-26 2011-07-11 Us Gov Health & Human Serv Allosteriske A3-adenosin-receptormodulatorer
JP5019851B2 (ja) * 2006-11-09 2012-09-05 学校法人 関西大学 温度応答性ゾル−ゲル転移を示す生分解性ポリマー及びその製造方法
US8871242B2 (en) 2006-11-17 2014-10-28 National Cerebral And Cardiovascular Center Blood anticoagulant material, coating material and indwelling device comprising the same, and treatment using blood anticoagulant material
FI3660073T3 (fi) * 2007-02-15 2023-09-11 Tolmar International Ltd Matalan purskeen poly(laktidi-ko-glykolidi)
FR2915683B1 (fr) 2007-05-03 2009-08-07 Flamel Technologies Sa Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
CN101333295B (zh) * 2007-06-27 2011-01-05 中国科学院化学研究所 一种生物可降解高分子纳米粒子及其专用聚合物和它们的制备方法
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
US8642062B2 (en) * 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
JP4824710B2 (ja) * 2008-02-08 2011-11-30 国立清華大学 グラフト共重合体およびブロック共重合体の多機能混合ミセルならびにその製造方法
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
US9271929B2 (en) * 2008-11-25 2016-03-01 École Polytechnique Fédérale De Lausanne (Epfl) Block copolymers and uses thereof
DK2478066T3 (en) * 2009-09-18 2017-06-19 Protherics Medicines Dev Ltd BAB TRIBLOCK POLYMERS WITH IMPROVED DELIVERY CHARACTERISTICS
EP2382966A1 (de) * 2010-03-12 2011-11-02 DSM IP Assets B.V. Mizellenzusammensetzungen und Herstellungsverfahren dafür
CN103209685A (zh) * 2010-03-26 2013-07-17 赢创有限公司 包含作为稳定剂的生物可降解的表面活性的嵌段共聚物的用于微囊化的乳液
CN102058909A (zh) * 2011-01-18 2011-05-18 复旦大学 聚乙二醇－共聚酯嵌段共聚物防粘连材料及其制备方法与应用
CN102181048B (zh) * 2011-03-11 2015-02-25 上海谊众生物技术有限公司 一种生物医用聚醚/聚酯嵌段共聚物的制备方法
CN102218027B (zh) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂
EP2596802A1 (de) 2011-11-23 2013-05-29 PLS-Design GmbH Pharmazeutische Zusammensetzung zur Behandlung allergischer Reaktionen
EP2813531B1 (de) * 2012-02-08 2018-11-21 Toray Industries, Inc. Stimulierbares material und medizinisches material damit
EP2674168A1 (de) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation von Effektor-T-Zell-Antworten durch lokale Depletion des Komplement-Faktors C3
EP2674167A1 (de) 2012-06-14 2013-12-18 PLS-Design GmbH Kontrollierte Aktivierung von Komplement-Komponenten zur Verwendung als endogener Hilfsstoff
JP6119608B2 (ja) * 2012-09-24 2017-04-26 東レ株式会社 ブロック共重合体の製造方法
CN103772686B (zh) 2012-10-26 2015-01-07 苏州雷纳药物研发有限公司 一种两亲性嵌段共聚物及其制备方法、以及该共聚物与抗肿瘤药物形成的胶束载药系统
EP2746396A1 (de) 2012-12-20 2014-06-25 PLS-Design GmbH Selektive örtliche Hemmung von TNFR1-vermittelten Funktionen am Ort von Antigen-/Allergenpräsentation
CN103611196B (zh) * 2013-04-17 2015-09-16 苏州工业园区汉德医院投资管理有限公司 一种pela/bmp-2微球及其制备方法
JP6176998B2 (ja) * 2013-05-13 2017-08-09 学校法人 関西大学 温度応答性生分解性高分子組成物及びその製造方法
CN104689380A (zh) * 2013-12-10 2015-06-10 复旦大学 一种由物理交联水凝胶构成的黏膜下注射材料及其应用
CN103819905B (zh) * 2014-03-07 2016-01-20 山东理工大学 一种用聚三亚甲基碳酸酯与聚乙烯吡咯烷酮对聚肽膜亲水性进行改进的方法
EP2918262B1 (de) 2014-03-10 2023-08-09 PLS-Design GmbH Induktion einer antigenspezifischen Toleranz durch periphere Phagozytose
CN104693431A (zh) * 2014-12-01 2015-06-10 周益峰 一种三嵌段聚合物及其制备方法和应用
CN104606129B (zh) * 2015-01-21 2018-05-04 中国人民解放军广州军区武汉总医院 罗哌卡因长效注射用温敏凝胶及其制备方法
AU2016211696B2 (en) 2015-01-27 2018-05-10 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
JP6584868B2 (ja) * 2015-02-25 2019-10-02 学校法人 関西大学 ゲル素材及びその製造方法
EP3095440B1 (de) 2015-05-19 2020-01-15 PLS-Design GmbH Antigen-spezifische immuntherapie mit toleranzinduzierenden liposomen
JP6886402B2 (ja) * 2015-08-24 2021-06-16 株式会社スリー・ディー・マトリックス 生分解性インジェクタブルゲル
CN105878174B (zh) * 2016-04-26 2021-06-29 广州帝奇医药技术有限公司 一种固体分散体及其制备方法与应用
CN106349466B (zh) * 2016-09-02 2019-09-20 广东众生药业股份有限公司 一种新的生物医用聚醚/聚酯嵌段共聚物的制备方法
US20200038323A1 (en) * 2017-03-31 2020-02-06 Rowan University Optically clear, in-situ forming biodegradable nano-carriers for ocular therapy, and methods using same
SG11201909997VA (en) * 2017-04-28 2019-11-28 Evonik Degussa Gmbh Biodegradable bone glue
WO2019076477A1 (en) 2017-10-18 2019-04-25 Luxembourg Institute Of Health (Lih) INDUCTION OF ALLERGEN-SPECIFIC TREGS PRIOR TO ORAL OR SUBLINGUAL IMMUNOTHERAPY OF FOOD ALLERGY
EP3723863A1 (de) 2017-10-18 2020-10-21 Luxembourg Institute of Health (LIH) In hydrogel eingebettete oligodesoxynukleotide als tolerogenes adjuvans zur subkutanen immuntherapie
CN109498804B (zh) * 2018-12-04 2022-07-26 中国人民解放军军事科学院军事医学研究院 一种温度响应型狂犬疫苗递送系统
EP3679928A1 (de) * 2019-01-08 2020-07-15 Atlangram Pharmazeutische zusammenetzung vom typ gel zur behandlung/vorbeugung einer infektion
CN110669184B (zh) * 2019-10-16 2022-05-31 临沂大学 一种具有药物释放功能的形状记忆高分子材料的制备方法及所得产品和应用
GB202103785D0 (en) * 2021-03-18 2021-05-05 UCB Biopharma SRL Formulations
CN114699566B (zh) * 2022-04-08 2022-12-20 海泽临床成果转化医学研究院(无锡)有限公司 一种可吸收结扎夹的制备方法
CN117547654A (zh) * 2023-12-04 2024-02-13 上海长征医院 一种仿生负载rhBMP-2骨修复材料及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058081T3 (es) * 1986-09-05 1994-11-01 American Cyanamid Co Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
FR2741628B1 (fr) * 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
CA2299393A1 (en) * 1997-08-08 1999-02-18 Sung Wan Kim Injectable biodegradable block copolymer gels for use in drug delivery

Also Published As

Publication number Publication date
JP2002516910A (ja) 2002-06-11
HK1031736A1 (en) 2001-06-22
CN1282345A (zh) 2001-01-31
JP4903256B2 (ja) 2012-03-28
CA2305621C (en) 2009-01-20
JP2012012606A (ja) 2012-01-19
DE69829204D1 (en) 2005-04-07
WO1999018142A1 (en) 1999-04-15
BR9815239A (pt) 2001-12-11
KR20010030889A (ko) 2001-04-16
BR9815239B1 (pt) 2010-07-13
CN1195788C (zh) 2005-04-06
AU9678098A (en) 1999-04-27
TR200000900T2 (tr) 2000-08-21
AR015175A1 (es) 2001-04-18
DE69829204T2 (de) 2005-12-15
KR100633939B1 (ko) 2006-10-16
ES2239408T3 (es) 2005-09-16
JP2010144178A (ja) 2010-07-01
KR20010030891A (ko) 2001-04-16
CA2305621A1 (en) 1999-04-15
PT1034207E (pt) 2005-07-29
IL135415A0 (en) 2001-05-20
JP4656725B2 (ja) 2011-03-23
EP1034207A1 (de) 2000-09-13
EP1034207A4 (de) 2002-04-17
AU736812B2 (en) 2001-08-02
EP1034207B1 (de) 2005-03-02
IL135415A (en) 2008-04-13

Similar Documents

Publication Publication Date Title
ATE290037T1 (de) Biologisch abbaubare triblock-poly(lactide-co- glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung
ZA989009B (en) Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
DE69937576D1 (de) Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung
EP0863745A4 (de) Thermosensitive biologisch abbaubare polymere auf basis von poly(ester-ester)blockcopolymeren
ID29222A (id) Polimer-polimer siloksan fotokurabel
IS5995A (is) Þríhringja hindrar fyrir pólý (ADP-róbósa) fjölliðara
DK0792311T3 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til fremstilling heraf samt anvendelse heraf til fremstilling af bionedbryd
DE60123772D1 (de) Mischungen von triblockcopolymeren von polyester-polyethylenglycol
ATE243718T1 (de) Poröse polyorganosiloxanpolymere
DE60039619D1 (de) Polymeren
DK0792312T3 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til fremstilling deraf samt deres anvendelse til fremstilling af bionedbryd
DE69905628D1 (de) Thermoplastische Polymerzusammensetzung
DE59812961D1 (de) Flammgeschützte polymerformmassen
FR2774096B1 (fr) Nouveaux copolymeres tensioactifs a base de methylidene malonate
DE60034380D1 (de) Wärmeschrumpfbarer Polyesterfilm
BR9707527A (pt) Composicões de inseticidas á base de polímeros
TR199700145A2 (tr) Genis mol kütle dagilimina sahip yüksek moleküler polipropilen.
DE69707275D1 (de) Dichter elektrochemischer generator mit endschutzschalter
DE60022427D1 (de) Wärmeschrumpfbare Polyesterfolie
ATE373028T1 (de) Polyolefinpfropfcopolymere mit fluorhaltigen monomeren
DE69907298D1 (de) Niedrigschmelzendes Tetrafluoroethylencopolymer
DE69908772D1 (de) Geraet mit kontextumschaltungsfaehigkeit
DK1034207T3 (da) Bionedbrydelige poly(lactid-co-glycolid)-polyethylenglycol-triblok-copolymerer med lav molekylvægt med omvendte termiske geleringsegenskaber
NO993326D0 (no) Polyester polykondensasjon med litiumtitanyloksalatkatalysator
ID25817A (id) Polimer-polimer dengan rantai gugus fluoroalkil sulfida

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1034207

Country of ref document: EP

EEFA Change of the company name